tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Protoporphyria, Erythropoietic D046351 1 associated lipids
Colitis, Collagenous D046729 1 associated lipids
Hepatic Insufficiency D048550 1 associated lipids
Diabetes Complications D048909 4 associated lipids
Dyslipidemias D050171 7 associated lipids
Atherosclerosis D050197 85 associated lipids
Granulomatosis, Orofacial D051261 2 associated lipids
Lymphohistiocytosis, Hemophagocytic D051359 1 associated lipids
Renal Insufficiency D051437 8 associated lipids
Delayed Graft Function D051799 2 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Huang K et al. Novel role for NFAT3 in ERK-mediated regulation of CXCR4. 2014 PLoS ONE pmid:25514788
Amorim J et al. Tacrolimus-induced neutropenia in a cardiac transplant patient. 2014 Pediatr Transplant pmid:24384051
Saso S et al. Uterine allotransplantation in a rabbit model using aorto-caval anastomosis: a long-term viability study. 2014 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:25306223
Meyer KC et al. An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome. 2014 Eur. Respir. J. pmid:25359357
Ahmed S et al. Photocleavable dimerizer for the rapid reversal of molecular trap antagonists. 2014 J. Biol. Chem. pmid:24421317
Al-Amri AM Long-term follow-up of tacrolimus ointment for treatment of atopic keratoconjunctivitis. 2014 Am. J. Ophthalmol. pmid:24439439
Kim JR et al. 20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol-fortified ginseng extract attenuates the development of atopic dermatitis-like symptoms in NC/Nga mice. 2014 J Ethnopharmacol pmid:24269244
Lin Y et al. PERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseases. 2014 Am. J. Pathol. pmid:24269558
Koren G and Rieder M Measuring oral bioavailability of tacrolimus. 2014 Pediatr Transplant pmid:25250966
Ueda K et al. Early corticosteroid withdrawal in the real world: a long-term analysis of kidney transplant recipients from the Mycophenolic Acid Observational Renal Transplant Registry. 2014 Ann. Transplant. pmid:24535029
Görzer I et al. Plasma DNA levels of Torque teno virus and immunosuppression after lung transplantation. 2014 J. Heart Lung Transplant. pmid:24559947
Barnieh L et al. The cost of kidney transplant over time. 2014 Prog Transplant pmid:25193726
Guy S et al. Successful treatment of acute severe graft-versus-host-disease in a pancreas-after-kidney transplant recipient: case report. 2014 Transplant. Proc. pmid:25179161
Yuan C et al. A simple and robust LC-MS/MS method for measuring sirolimus and everolimus in whole blood. 2014 Bioanalysis pmid:25077621
Beermann KJ et al. Tacrolimus dose requirements in African-American and Caucasian kidney transplant recipients on mycophenolate and prednisone. 2014 Clin Transplant pmid:24754564
Matia I et al. Immunosuppressive protocol with delayed use of low-dose tacrolimus after aortic transplantation suppresses donor-specific anti-MHC class I and class II antibody production in rats. 2014 Ann. Transplant. pmid:24815872
Harada N et al. [Follow-up study on patients with vernal keratoconjunctivitis undergoing topical 0.1% tacrolimus treatment]. 2014 Nippon Ganka Gakkai Zasshi pmid:24864437
Izumi Y et al. Safety of tacrolimus treatment during pregnancy and lactation in systemic lupus erythematosus: a report of two patients. 2014 Tohoku J. Exp. Med. pmid:25175032
Anderson JS et al. Statistical allosteric coupling to the active site indole ring flip equilibria in the FK506-binding domain. 2014 Biophys. Chem. pmid:25016286
Lunde I et al. The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients. 2014 Eur. J. Clin. Pharmacol. pmid:24658827
Webster P et al. Tacrolimus is an effective treatment for lupus nephritis in pregnancy. 2014 Lupus pmid:24928830
Carbajo-Lozoya J et al. Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir. 2014 Virus Res. pmid:24566223
Ren Y et al. Tolerogenic dendritic cells modified by tacrolimus suppress CD4(+) T-cell proliferation and inhibit collagen-induced arthritis in mice. 2014 Int. Immunopharmacol. pmid:24836681
Li H et al. A promising approach of overcoming the intrinsic resistance of Candida krusei to fluconazole (FLC)--combining tacrolimus with FLC. 2014 FEMS Yeast Res. pmid:24830342
Welzl K et al. Effect of different immunosuppressive drugs on immune cells from young and old healthy persons. 2014 Gerontology pmid:24434865
Yang LM et al. Experimental research on end-to-side anastomosis of peripheral nerves and effect of FK506 on end-to-side anastomosis. 2014 Bratisl Lek Listy pmid:25573729
Taimur S et al. Donor T-cell chimerism and early post-transplant cytomegalovirus viremia in patients treated with myeloablative allogeneic hematopoietic stem cell transplant. 2014 Transpl Infect Dis pmid:24251680
Stewart JI et al. Reverse halo sign on chest imaging in a renal transplant recipient. 2014 Transpl Infect Dis pmid:24289813
Nacif LS et al. An analysis of tacrolimus-related complications in the first 30 days after liver transplantation. 2014 Clinics (Sao Paulo) pmid:25518032
Nishimoto K et al. [Case of organizing pneumonia associated with sweet's syndrome]. 2014 Arerugi pmid:25163580
Elens L et al. Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocks. 2014 Br J Clin Pharmacol pmid:24118098
Heilman RL et al. Delayed allograft inflammation following alemtuzumab induction for kidney transplantation. 2013 Sep-Oct Clin Transplant pmid:23924146
Benoit S and Hamm H Psoriasis from a prosthesis: unusual Koebner phenomenon in a girl with autoamputation of the leg. 2013 Sep-Oct Pediatr Dermatol pmid:23360396
Zahdi MR et al. Erosive pustular dermatosis of the scalp successfully treated with oral prednisone and topical tacrolimus. 2013 Sep-Oct An Bras Dermatol pmid:24173187
Riva N et al. [Pharmacovigilance of calcineurin inhibitor in peidatric kidney and liver transplantation]. 2013 Nov-Dec Farm Hosp pmid:24256007
Brodrick B et al. Influence of treatments on prognosis for vulvar lichen sclerosus: facts and controversies. 2013 Nov-Dec Clin. Dermatol. pmid:24160287
Bloom RD et al. A randomized, crossover pharmacokinetic study comparing generic tacrolimus vs. the reference formulation in subpopulations of kidney transplant patients. 2013 Nov-Dec Clin Transplant pmid:24118450
Labirua-Iturburu A et al. Calcineurin inhibitors in a cohort of patients with antisynthetase-associated interstitial lung disease. 2013 May-Jun Clin. Exp. Rheumatol. pmid:23465087
Chen SY et al. Individualization of tacrolimus dosage basing on cytochrome P450 3A5 polymorphism--a prospective, randomized, controlled study. 2013 May-Jun Clin Transplant pmid:23432535
Ramirez CB et al. Completely steroid-free immunosuppression in liver transplantation: a randomized study. 2013 May-Jun Clin Transplant pmid:23621629
Krishna N et al. Tacrolimus-induced paranoid delusions and fugue-like state. 2013 May-Jun Gen Hosp Psychiatry pmid:22959421
He L et al. Treatment of idiopathic membranous nephropathy with combination of low-dose tacrolimus and corticosteroids. 2013 May-Jun J. Nephrol. pmid:22956434
Kanzelmeyer NK et al. Correlations with six-month protocol biopsy findings in pediatric transplant recipients on low- and regular-dose CNI regimens. 2013 Mar-Apr Clin Transplant pmid:23414365
Tiwari R et al. Enhancements in healthcare information technology systems: customizing vendor-supplied clinical decision support for a high-risk patient population. 2013 Mar-Apr J Am Med Inform Assoc pmid:22813760
Albekairy A et al. Cytochrome P450 3A4FNx011B as pharmacogenomic predictor of tacrolimus pharmacokinetics and clinical outcome in the liver transplant recipients. 2013 Mar-Apr Saudi J Gastroenterol pmid:23481136
LaMattina JC et al. Native kidney function following liver transplantation using calcineurin inhibitors: single-center analysis with 20 years of follow-up. 2013 Mar-Apr Clin Transplant pmid:23294013
Alfson ED et al. Lysis of catatonic withdrawal by propofol in a bone-marrow transplant recipient with adenovirus limbic encephalitis. 2013 Mar-Apr Psychosomatics pmid:22705183
Yoshida EM et al. Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection. 2013 Mar-Apr Ann Hepatol pmid:23396740
Castillo G et al. [Acute cellular rejection in a liver transplantation patient due to changing the brand of a generic immunosuppressant]. 2013 Jul-Sep Rev Gastroenterol Mex pmid:23866966
Bechstein WO et al. A comparative, randomized trial of concentration-controlled sirolimus combined with reduced-dose tacrolimus or standard-dose tacrolimus in renal allograft recipients. 2013 Jul-Aug Transplant. Proc. pmid:23953523
Zhao YJ et al. Late, severe, noninfectious diarrhea after renal transplantation: high-risk factors, therapy, and prognosis. 2013 Jul-Aug Transplant. Proc. pmid:23953533
Weiler N et al. Tacrolimus effects and side effects after liver transplantation: is there a difference between immediate and extended release? 2013 Jul-Aug Transplant. Proc. pmid:23953543
Stringa P et al. Ischemic preconditioning and tacrolimus pretreatment as strategies to attenuate intestinal ischemia-reperfusion injury in mice. 2013 Jul-Aug Transplant. Proc. pmid:23953566
Tachibana A et al. Repopulation of the immunosuppressed retrorsine-treated infant rat liver with human hepatocytes. 2013 Jul-Aug Xenotransplantation pmid:23683097
Favi E et al. Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. 2013 Jul-Aug Clin Transplant pmid:23710603
Eberlin M et al. Increased medication compliance of liver transplant patients switched from a twice-daily to a once-daily tacrolimus-based immunosuppressive regimen. 2013 Jul-Aug Transplant. Proc. pmid:23726723
Satyanarayan HS et al. Efficacy and tolerability of combined treatment with NB-UVB and topical tacrolimus versus NB-UVB alone in patients with vitiligo vulgaris: a randomized intra-individual open comparative trial. 2013 Jul-Aug Indian J Dermatol Venereol Leprol pmid:23760325
Babalola O and Strober BE Treatment of atopic dermatitis in pregnancy. 2013 Jul-Aug Dermatol Ther pmid:23914886
Conti R et al. Jessner-Kanof disease: two effective and sure therapeutic options. 2013 Jul-Aug Dermatol Ther pmid:23914897
Chakkera HA et al. Genetic differences in Native Americans and tacrolimus dosing after kidney transplantation. 2013 Jan-Feb Transplant. Proc. pmid:23375287
Tian Ch et al. B- and T-lymphocyte attenuator/herpes virus entry mediator as early indicators for acute rejection following kidney transplantation. 2013 Jan-Feb Transplant. Proc. pmid:23375291
Yao B et al. The incidence of posttransplantation diabetes mellitus during follow-up in kidney transplant recipients and relationship to Fok1 vitamin D receptor polymorphism. 2013 Jan-Feb Transplant. Proc. pmid:23375298
Miyazaki T et al. Two case reports of successful withdrawal of mycofenolate mofetil after living donor lobar lung transplantation. 2013 Jan-Feb Transplant. Proc. pmid:23375323
Chang HY et al. Long-term follow-up of arrhythmia characteristics and clinical outcomes in heart transplant patients. 2013 Jan-Feb Transplant. Proc. pmid:23375324
Al Nahdi N et al. First successful treatment of post-liver transplant hepatitis C fibrosing cholestatic hepatitis with boceprevir, peginterferon and ribavirin in a pre-transplant null responder. 2013 Jan-Feb Ann Hepatol pmid:23293209
Seco-Melantuche R et al. [Incidence of drug-induced thrombocytopenia in hospitalized patients]. 2013 Jan-Feb Farm Hosp pmid:23461497
Rao V et al. A non-induction renal sparing approach after liver transplantation: high dose mycophenolate mofetil with delayed, low-dose tacrolimus. 2013 Jan-Feb Transplant. Proc. pmid:23267806
Langone A et al. Does reduction in mycophenolic acid dose compromise efficacy regardless of tacrolimus exposure level? An analysis of prospective data from the Mycophenolic Renal Transplant (MORE) Registry. 2013 Jan-Feb Clin Transplant pmid:22861144
Shiba H et al. Switching from tacrolimus to cyclosporine A to prevent primary biliary cirrhosis recurrence after living-donor liver transplantation. 2013 Apr-Jun Int Surg pmid:23701152
Adamu B et al. New-onset diabetes after renal transplantation: a case series as seen in a Nigerian kidney transplant population. 2013 Apr-Jun Niger J Clin Pract pmid:23563475
Cangemi G et al. Comparison of antibody-conjugated magnetic immunoassay and liquid chromatography-tandem mass spectrometry for the measurement of cyclosporine and tacrolimus in whole blood. 2013 Apr-Jun Int J Immunopathol Pharmacol pmid:23755756
Yoshikawa Y et al. [Pre-evening meal administration of tacrolimus improved refractory ocular symptoms in two young children with latent general myasthenia gravis]. 2013 No To Hattatsu pmid:23951946
Preidl RH et al. Clopidogrel reduces post-transplant obliterative bronchiolitis. 2013 Transpl. Int. pmid:23952051
Mignogna MD et al. Clinical behaviour and long-term therapeutic response in orofacial granulomatosis patients treated with intralesional triamcinolone acetonide injections alone or in combination with topical pimecrolimus 1%. 2013 J. Oral Pathol. Med. pmid:22784292
Westland T et al. Treatment of atopic keratoconjunctivitis in patients with atopic dermatitis: is ocular application of tacrolimus an option? 2013 J Eur Acad Dermatol Venereol pmid:23106347
Pan F et al. [Protective effect of tacrolimus postconditioning on oxidative stress injury provoked by spinal cord ischemia-reperfusion in rats]. 2013 Zhonghua Yi Xue Za Zhi pmid:24548402
Mesar I et al. Rescue therapy with sirolimus in a renal transplant recipient with tacrolimus-induced hepatotoxicity. 2013 Ren Fail pmid:24028307
Dong QE et al. [Inhibitory effects of tacrolimus on effector T cells from patients with severe aplastic anemia]. 2013 Zhonghua Yi Xue Za Zhi pmid:24028719
Bourdeaux C et al. Prope tolerance after pediatric liver transplantation. 2013 Pediatr Transplant pmid:23171043
Prucha H et al. Pimecrolimus, a topical calcineurin inhibitor used in the treatment of atopic eczema. 2013 Expert Opin Drug Metab Toxicol pmid:23876065
Kim CH et al. 850nm light-emitting-diode phototherapy plus low-dose tacrolimus (FK-506) as combination therapy in the treatment of Dermatophagoides farinae-induced atopic dermatitis-like skin lesions in NC/Nga mice. 2013 J. Dermatol. Sci. pmid:23810774
Rickels MR et al. Improvement in insulin sensitivity after human islet transplantation for type 1 diabetes. 2013 J. Clin. Endocrinol. Metab. pmid:24085506
Renner B et al. Cyclosporine induces endothelial cell release of complement-activating microparticles. 2013 J. Am. Soc. Nephrol. pmid:24092930
Michel S et al. Renal recovery after conversion to an everolimus-based immunosuppression in early and late heart transplant recipients: a 12-month analysis. 2013 Exp Clin Transplant pmid:24128136
Kim Y et al. Patients with persistent new-onset diabetes after transplantation have greater weight gain after kidney transplantation. 2013 J. Korean Med. Sci. pmid:24133345
Vichyanond P and Kosrirukvongs P Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis. 2013 Curr Allergy Asthma Rep pmid:23625179
Wang Y et al. Micelles of methoxy poly(ethylene glycol)-poly(epsilon-caprolactone) as a novel drug delivery vehicle for tacrolimus. 2013 J Biomed Nanotechnol pmid:23627041
Axelsson J et al. Scavengers of reactive oxygen species, paracalcitol, RhoA, and Rac-1 inhibitors and tacrolimus inhibit angiotensin II-induced actions on glomerular permeability. 2013 Am. J. Physiol. Renal Physiol. pmid:23657856
Lee Sr et al. Angiotensinogen polymorphisms and post-transplantation diabetes mellitus in Korean renal transplant subjects. 2013 Kidney Blood Press. Res. pmid:23594830
Casanova JR et al. Rapid hippocampal network adaptation to recurring synchronous activity--a role for calcineurin. 2013 Eur. J. Neurosci. pmid:23879713
Eguchi R et al. FK506 induces endothelial dysfunction through attenuation of Akt and ERK1/2 independently of calcineurin inhibition and the caspase pathway. 2013 Cell. Signal. pmid:23707520
Fitzgerald RT et al. Isolated leptomeningeal enhancement in tacrolimus-associated posterior reversible encephalopathy syndrome. 2013 Pediatr. Neurol. pmid:23290027
van Maarseveen EM et al. Pretransplantation pharmacokinetic curves of tacrolimus in HIV-infected patients on ritonavir-containing cART: a pilot study. 2013 Transplantation pmid:23250333
Han N et al. Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients. 2013 Eur. J. Clin. Pharmacol. pmid:22660440
Oteo I et al. Tacrolimus pharmacokinetics in the early post-liver transplantation period and clinical applicability via Bayesian prediction. 2013 Eur. J. Clin. Pharmacol. pmid:22660442
Bashratyan R et al. Insulinoma-released exosomes activate autoreactive marginal zone-like B cells that expand endogenously in prediabetic NOD mice. 2013 Eur. J. Immunol. pmid:23817982
Yin H et al. Enhancing pancreatic Beta-cell regeneration in vivo with pioglitazone and alogliptin. 2013 PLoS ONE pmid:23762423
Tie X et al. NFAT1 is highly expressed in, and regulates the invasion of, glioblastoma multiforme cells. 2013 PLoS ONE pmid:23762456
Rice SA et al. Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn's Disease. 2013 BMC Res Notes pmid:23331739
Kanda J et al. Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment. 2013 Bone Marrow Transplant. pmid:23334274